Aprea Therapeutics Inc

NASDAQ:APRE 3:50:49 PM EDT

3.61

-0.14 (-3.73%)

5:10:56 PM EDT: $3.75 +0.14 (+3.88%)

Market Cap (Intraday)	13.49M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.17 Million
Adjusted EPS	-$0.77

See more estimates

10-Day MA	$3.76
50-Day MA	$4.20
200-Day MA	$4.07

See more pivots

Aprea Therapeutics Inc Stock, NASDAQ:APRE

3805 Old Easton Road, Doylestown, Pennsylvania 18902

United States of America

Phone: +1.617.463.9385

Number of Employees: 9

http://www.aprea.com

Description

Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of cancer therapeutics. It is involved in the development and commercialization of novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wen Jie Bao in 2002 and is headquartered in Doylestown, PA.